"Piperacillin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Semisynthetic, broad-spectrum, AMPICILLIN derived ureidopenicillin antibiotic proposed for PSEUDOMONAS infections. It is also used in combination with other antibiotics.
Descriptor ID |
D010878
|
MeSH Number(s) |
D02.065.589.099.750.750.050.650 D02.886.108.750.750.050.650 D03.633.100.300.750.750.050.650
|
Concept/Terms |
Piperacillin Sodium- Piperacillin Sodium
- Sodium, Piperacillin
- Piperacillin Monosodium Salt
- Monosodium Salt, Piperacillin
- Salt, Piperacillin Monosodium
AB-Piperacillin- AB-Piperacillin
- AB Piperacillin
- Piperacillin Curasan
- Curasan, Piperacillin
|
Below are MeSH descriptors whose meaning is more general than "Piperacillin".
Below are MeSH descriptors whose meaning is more specific than "Piperacillin".
This graph shows the total number of publications written about "Piperacillin" by people in this website by year, and whether "Piperacillin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 0 | 1 | 1 |
2001 | 1 | 2 | 3 |
2003 | 0 | 1 | 1 |
2008 | 1 | 1 | 2 |
2009 | 0 | 1 | 1 |
2010 | 0 | 1 | 1 |
2015 | 0 | 2 | 2 |
2017 | 0 | 1 | 1 |
2019 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Piperacillin" by people in Profiles.
-
Optimal Piperacillin-Tazobactam Dosing Strategies against Extended-Spectrum-?-Lactamase-Producing Enterobacteriaceae. Antimicrob Agents Chemother. 2019 02; 63(2).
-
A novel framework to compare the effectiveness of ?-lactamase inhibitors against extended-spectrum ?-lactamase-producing Enterobacteriaceae. Clin Microbiol Infect. 2019 Sep; 25(9):1154.e9-1154.e14.
-
Antimicrobial Activities of Ceftazidime-Avibactam and Comparator Agents against Clinical Bacteria Isolated from Patients with Cancer. Antimicrob Agents Chemother. 2017 04; 61(4).
-
Fever and Reversible Laboratory Abnormalities Associated with Prolonged Use of Piperacillin-Tazobactam in Children. Pediatr Infect Dis J. 2015 Aug; 34(8):849-50.
-
Microbiological and clinical features of four cases of catheter-related infection by Methylobacterium radiotolerans. J Clin Microbiol. 2015 Apr; 53(4):1375-9.
-
Mathematical modeling to characterize the inoculum effect. Antimicrob Agents Chemother. 2010 Nov; 54(11):4739-43.
-
Killing of Escherichia coli by beta-lactams at different inocula. Diagn Microbiol Infect Dis. 2009 Jun; 64(2):166-71.
-
Killing activity of rifampin with piperacillin therapy against adherent cells of Pseumodomas aeruginosa. J Chemother. 2008 Oct; 20(5):652-4.
-
Outcomes of bacteremia due to Pseudomonas aeruginosa with reduced susceptibility to piperacillin-tazobactam: implications on the appropriateness of the resistance breakpoint. Clin Infect Dis. 2008 Mar 15; 46(6):862-7.
-
Ciprofloxacin versus tobramycin for neutropenic fevers. Ann Intern Med. 2003 Mar 04; 138(5):435; author reply 436.